TTM
$57.31M
YoY change
+364.3%
5Y CAGR
—
Peak year (2025)
$147.30M
Cumulative EBITDA
−$348.97M
EBITDA history chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: $147.30M
EBITDA growth chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: +364.3%
EBITDA history table for Teladoc Health (TDOC) from 2013 to 2025
| 2025 | $147.30M | +364.3% | +$115.58M | ||
| 2024 | $31.72M | -27.3% | −$11.89M | ||
| 2023 | $43.61M | -678.7% | +$51.15M | ||
| 2022 | −$7.54M | -76.0% | +$23.88M | ||
| 2021 | −$31.42M | -91.1% | +$323.08M | ||
| 2020 | −$354.49M | +916.6% | −$319.62M | ||
| 2019 | −$34.87M | +14.9% | −$4.51M | ||
| 2018 | −$30.36M | -29.6% | +$12.74M | ||
| 2017 | −$43.10M | -2.7% | +$1.17M | ||
| 2016 | −$44.28M | -6.1% | +$2.86M | ||
| 2015 | −$47.14M | +286.2% | −$34.94M | ||
| 2014 | −$12.21M | +148.3% | −$7.29M | ||
| 2013 | −$4.92M | — | — |
- 2025$147.30M+364.3%
- 2024$31.72M-27.3%
- 2023$43.61M-678.7%
- 2022−$7.54M-76.0%
- 2021−$31.42M-91.1%
- 2020−$354.49M+916.6%
- 2019−$34.87M+14.9%
- 2018−$30.36M-29.6%
- 2017−$43.10M-2.7%
- 2016−$44.28M-6.1%
- 2015−$47.14M+286.2%
- 2014−$12.21M+148.3%
- 2013−$4.92M—
EBITDA values are taken from Teladoc Health's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Teladoc Health (TDOC)
According to Teladoc Health's latest reported financial statements, the company's current EBITDA (TTM) is $57.31M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Teladoc Health (TDOC) reported EBITDA of $147.30M – surged 364.3% year-over-year.
Across the available history, EBITDA reached its high of $147.30M in 2025 and its low of −$354.49M in 2020.
Teladoc Health EBITDA by Year
Teladoc Health EBITDA 2025: $147.30M
Teladoc Health EBITDA in 2025 was $147.30M, surged 364.3% from 2024. This figure represents the highest annual value in the available history.
Teladoc Health EBITDA 2024: $31.72M
2024's EBITDA for Teladoc Health came in at $31.72M, declined 27.3% below 2023.
Teladoc Health EBITDA 2023: $43.61M
Teladoc Health posted EBITDA of $43.61M in 2023, plunged 678.7% below 2022.
Teladoc Health EBITDA 2022: −$7.54M
In 2022, Teladoc Health reported EBITDA of −$7.54M, plunged 76.0% below 2021.
Teladoc Health EBITDA 2021: −$31.42M
Teladoc Health EBITDA in 2021 was −$31.42M.
See more financial history for Teladoc Health (TDOC).
Sector peers by EBITDA
Healthcare peers of Teladoc Health (TDOC), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation